Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B
5b
(CYB5B)
Molecular Cancer, Volume 9, Article 14, Year 2010
Notification
URL copied to clipboard!
Description
Background: We have previously reported a novel constitutively overexpressed 21 kDa protein in Hodgkin Lymphoma (HL) and aggressive Non-Hodgkin Lymphomas (NHL). The objective of the current study was to 1) identify this protein using two independent methods, 2) study the expression of the protein and its encoding mRNA in reactive lymph nodes, normal lymphocytes and CD34+ bone marrow precursor cells, 3) analyse patterns of expression of the protein in tissue microarrays assembled from a large number of diagnostic clinical biopsies from patients with HL, and 4) determine the copy number variation and mutation status of the encoding gene in HL cell lines.Results: Peptide sequencing by LC-MS/MS and protein identification by protein array screening identified a single protein, CYB5B. No mutations were detected in the CYB5B gene in HL cell lines. Quantitative PCR showed CYB5B gene expression was increased in HL and NHL cell lines. Array CGH using a submegabase resolution tiling array revealed gains in the CYB5B locus in HL cell lines KMH2 and L428. Membrane expression was seen in Reed-Sternberg cells in clinical biopsies from patients with HL but not in reactive lymph nodes. Bone marrow CD34+ precursor cells were CYB5B negative on the cell surface. RT-PCR assays of RNA extracted from T and B cell enriched fractions obtained from normal peripheral blood mononuclear cells, reactive lymph nodes, tonsils and normal bone marrow samples showed no evidence of increased mRNA levels of CYB5B in comparison to housekeeping gene GAPDH.Conclusions: The 21 kDa protein overexpressed in HL and aggressive NHL is identical to CYB5B. CYB5B gene expression is increased in a subset of HL and NHL cell lines tested. This is associated with CYB5B gene amplification in HL cell lines KMH2 and L428. CYB5B may be a potential target for antibody-based therapy of HL and aggressive NHL as although cytoplasmic expression is present in reactive lymphocytes, it is not expressed on the cell surface of non-neoplastic lymphocytes or bone marrow precursor cells. © 2010 Murphy et al; licensee BioMed Central Ltd.
Authors & Co-Authors
Murphy, Derek
Ireland, Dublin
Royal College of Surgeons in Ireland
Parker, Jeremy
Canada, Vancouver
Bc Cancer Research Centre
Zhou, Minglong
Canada, Vancouver
Provincial Health Services Authority
Fadlelmola, Faisal M.
Canada, Vancouver
Provincial Health Services Authority
Botswana, Gaborone
University of Botswana
Steidl, Christian
Canada, Vancouver
Provincial Health Services Authority
Karsan, Aly
Canada, Vancouver
Bc Cancer Research Centre
Gascoyne, Randy D.
Canada, Vancouver
Provincial Health Services Authority
Canada, Vancouver
Bc Cancer Research Centre
Chen, Hong
Ireland, Dublin
Royal College of Surgeons in Ireland
Banerjee, Diponkar
Canada, Vancouver
Provincial Health Services Authority
Statistics
Citations: 18
Authors: 9
Affiliations: 4
Identifiers
Doi:
10.1186/1476-4598-9-14
e-ISSN:
14764598
Research Areas
Cancer
Genetics And Genomics
Study Approach
Quantitative